耿美玉，中国科学院上海药物研究所党委书记、副所长、研究员、课题组长；国家“973”计划“糖化学糖生物学研究”项目首席科学家。主要从事抗阿尔茨海默病和抗肿瘤分子靶向药物研发和生物标志物研究，领衔研发的抗阿尔茨海默病药物正在临床III期研究，3个分子靶向抗肿瘤药物正在进行系统的临床前评价。系统阐明了数十个自主研发的分子靶向药物的新作用机制，发现了数个疗效预测与疗效监控生物标志物。在TiPS、J Nat Cancer Inst、Cancer Res、Intl J Cancer、Oncotarget、Mol Pharmacol、J Biol Chem、J Med Chem等SCI学术杂志上发表了100余篇论文。研究成果获国家技术发明奖一等奖一项（第五名）、“上海市优秀学科带头人”、“上海市领军人才”、“上海市五一巾帼创新奖”等多项奖励。2009年入选上海领军人才，2010年入选“上海市优秀学科带头人”，2013年被授予“有突出贡献中青年专家”称号。 教育经历 1980.9-1989.7， 山东大学，本科、硕士 1993.10-1997.8， 日本东京大学药学部，博士 工作经历 1999.12- 2006.5， 中国海洋大学 博士生导师 2006.5-至今， 上海药物研究所 研究员 2011.5-2014.3， 上海药物研究所 副所长/党委副书记 2014.3-至今，上海药物研究所 副所长/党委书记

1.靶向Aβ抗阿尔茨海默病药物研发 2.激酶c-Met、ALK、FGFR抑制剂及其生物标志物 3.Hsp90抑制剂及其生物标志物 4.肿瘤代谢及其治疗策略 5.肿瘤微环境及其治疗策略

Ai J, Tang Q, Wu Y, Xu Y, Teng F, Zhou R, Gao X, Zhu Q, Yue X, Pan Q, Xu S, Li J, Huang M, Daugherty-Holtrop J, He Y, Xu H, Fan J, Ding J, Geng M*. The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma. J Natl Cancer Inst. 2011; 103(22):1696-1712. Huang M, Shen A, Ding J, Geng M*. Molecularly targeted cancer therapy: some lessons from the past decade. Trends Pharmacol Sci. 2014; 35(1):41-50. Zhao H, Liu H, Chen Y, Xin X, Li J, Hou Y, Zhang Z, Zhang X, Xie C, Geng M*, Ding J. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis. Cancer Research. 2006; 66(17):8779-8787. Tang Q, Wang L, Tao K, Ge C, Li J, Peng Y, Jiang C, Geng M*. Expression of polymeric immunoglobulin receptor mRNA and protein in human paneth cells: Paneth cells participate in acquired immunity. Am J Gastroenterol. 2006; 101(7):1625-1632. Huang X, Sun D, Pan Q, Wen W, Chen Y, Xin X, Huang M, Ding J, Geng M*. JG6, a novel marine-derived oligosaccharide, suppresses breast cancer metastasis via binding to cofilin. Oncotarget. 2014;5(11):3568-78. IF: 6.636 Du L, Ai J, Li D, Zhu T, Wang Y, Knauer M, Bruhn T, Liu H, Geng M*, Gu Q, Bringmann G. Aspergiolides C and D: spirocyclic aromatic polyketides with potent protein kinase c-Met inhibitory effects. Che. Eur J. 2011; 17(4):1319-1326. Zhang J, Xin X, Chen Q, Xie Z, Gui M, Chen Y, Lin L, Feng J, Li Q, Ding J, Geng M*. Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-kappa B via targeting of Mre11. Int J Cancer. 2012; 130(2):467-477. Yang S, Zhang X, Ai J, Gan L, Xu J, Wang Y, Su Z, Wang L, Ding J, Geng M*, Yue J. Potent HGF/c-Met axis inhibitors from Eucalyptus globulus: the coupling of phloroglucinol and sesquiterpenoid is essential for the activity. J Med Chem. 2012; 55(18):8183-8187. Huang X, Pan Q, Sun D, Chen W, Shen A, Huang M, Ding J, Geng M*. O-GlcNAcylation of cofilin promotes breast cancer cell invasion. J Biol Chem. 2013; 288(51):36418-36425. Zhu C, Chen Q, Xie Z, Ai J, Tong L, Ding J, Geng M*. The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc. J Mol Med. 2011; 89(3):279-289.